Meng et al. [26] also demonstrated in the same animal model an improvement of inflammation in the aorta, reducing serum levels of IL-1β, plasma TAG, and lipid deposition in the aorta, in addition to a reduction of hepatic steatosis with estradiol treatment. Here, IL1B is linked to fatty liver disease.